Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,215,802
+$3,921,422 QoQ
Shares Held
63,008
+274.3% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 303 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
98,864 | $53,567,481 | |
| 2 | ZTS |
Zoetis Inc.
|
241,369 | $17,344,776 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,081,523 | $10,815,230 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
295,918 | $10,025,701 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
387,530 | $7,820,355 | |
| 6 | HLN |
Haleon plc
|
682,281 | $6,365,681 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
This page
|
63,008 | $5,215,802 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
278,706 | $4,467,657 |
All Filings in ANIP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,215,802 | 63,008 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,294,380 | 16,832 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,740,627 | 22,050 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,668,213 | 40,046 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $2,226,844 | 40,283 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $1,578,878 | 28,634 | Shares | Defined | 2024-02-09 | |
| 2023-03-31 | $367,211 | 9,245 | Shares | Defined | 2023-05-12 | |
| 2021-09-30 | $264,660 | 8,064 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||